National and Kapodistrian University of Athens
Η κλινική σημασία της ανίχνευσης αγγειογενετικών παραγόντων σε ασθενείς με διαφοροποιημένο καρκίνο θυρεοειδούς αδένα
Abstract
dc:descriptionAim: Differentiated thyroid cancer (DTC) is the most common malignancy affecting the endocrine system. Thus, improving our understanding of the underlying mechanisms leading to tumorgenensis is of vital importance. Angiogenesis is a key mechanism in the development of several types of cancer. Previous studies have indicated that angiogenesis is a key factor in DTC progression. In the present study, we examined circulating levels of angiogenesis-related factors Angiopoietin-1, Angiopoietin-2, Vascular Endothelial Growth Factor-A (VEGF-A), Galectin-3 (Gal-3), urokinase type plasminogen activator receptor (uPAR) and plasminogen activation inhibitor -1 (PAI-1) were examined in patients with DTC and in control groups.Patients and methods: One hundred and thirty eight patients were enrolled, who were scheduled to undergo total thyroidectomy with a pre-operative diagnosis of DTC or multinodular goiter (MNG). Fifty eight euthyroid healthy individuals were recruited as controls. After definitive histopathological diagnosis, patients were divided into 3 groups: DTC, microcarcinoma and MNG. Prior to surgery blood samples were obtained to evaluate circulating levels of Ang-1, Ang-2, VEGF, uPAR and PAI-1 employing ELISA. In a random subset of 28 patients, six months after surgery, circulating levels of the afore-mentioned factors were measured again.Results: Significant lower levels of Ang-1 were observed in DTC and microcarcinoma patients as compared to healthy controls (37,790 ± 11,270 pg/ml and 37,190 ± 11,380 pg/ml vs 47,720 ± 20,630 pg/ml respectively, p<0.05). A more salient outcome was observed in patients with MNG as compared to controls (37,430 ± 11,370 pg/ml vs 47,720 ± 20,630 pg/ml, p<0.001). Elevated levels of PAI-1 were observed in microcarcinoma patients compared to controls but this difference failed to achieve significance (p=0.062). A significant increase in Ang-1 levels was observed post-operatively in the subset of patients that were reevaluated (41,690 ± 2,570 pg/ml vs 53,680 ± 3,250 pg/ml, p<0.05). No significant differences were observed in the levels of other factors (p<0.05).Conclusion: The results of this study indicate that the presence of benign (in this case MNG) or malignant disease of the thyroid significantly influences circulating levels of Ang-1. Complete removal of the gland leads to normalization of Ang-1 levels, 6 months after surgery. Further studies are needed to fully elucidate the clinical significance of these findings.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nixon, Alexandros-Mixail
- Νίξον, Αλέξανδρος-Μιχαήλ
Subjects
dc:subject × 16- Παράγοντες αγγειογένεσης
- Καρκίνος θυρεοειδούς
- Αγγειοποιητίνη
- Θηλώδης καρκίνος θυρεοειδούς
- Angiogenesis
- Thyroid cancer
- Papillary thyroid carcinoma
- Angiopoietin
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Χειρουργική
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
- Surgery
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50933